This is the consolidated, actionable to-do list of every volatile specific in the
wiki — the things you must confirm against an official source before relying on
them. Nothing here is asserted as fact; each row points you to where to get the real
answer. (The registry of sources is in ../../sources.md.)
Rule: any concrete number — dollars, hours, # of questions, %, passing score,
statute citation, deadline, case status — is VERIFY until checked against an
official source. When in doubt, downgrade: prefer VERIFY over a confident wrong
number.
- Pick a section below.
- For each row, open the official source and record the answer + the date you
checked.
- Re-verify periodically — these change.
| # |
Verify |
Official source |
Page |
| A1 |
Pre-licensing hours for P&C (and L&H) in WA / CA / NY; whether mandatory; any ethics-hour component |
WA OIC / CA DOI / NY DFS + vendor handbook |
PLE |
| A2 |
Which exam vendor each state uses (PSI / Pearson VUE / Prometric) |
State regulator → vendor site |
Exam |
| A3 |
# of questions, time limit, passing score per state/line |
Vendor’s current candidate handbook |
Exam |
| A4 |
Whether general + state portions are scored separately |
Vendor handbook |
Exam |
| A5 |
Exam content-outline % weightings per topic |
Vendor’s published content outline |
Exam |
| A6 |
Whether P&C is one combined exam or two; how L&H bundles |
State regulator + vendor handbook |
Lines of authority |
| # |
Verify |
Official source |
Page |
| B1 |
Whether fingerprinting is required (WA / CA / NY), vendor, fee |
State regulator background-check instructions |
Background check |
| B2 |
Whether prints/check happen before or after the exam |
State regulator |
Background check |
| B3 |
Application / exam / license / renewal fees per state and line |
State fee schedules + NIPR/Sircon at filing |
Application |
| B4 |
How a prior conviction / bankruptcy / child-support arrearage is evaluated; waiver process |
State regulator (+ counsel) |
Background check |
| # |
Verify |
Official source |
Page |
| C1 |
CE hours (+ ethics subset) and renewal cycle per state |
State regulator CE/renewal pages |
Application |
| C2 |
Non-resident reciprocity treatment (esp. NY & CA deviations) |
State regulator + NAIC PLMA status |
Reciprocity |
| C3 |
Whether NIPR or Sircon is the accepted portal per transaction/state |
nipr.com / sircon.com / state regulator |
NIPR & Sircon |
| # |
Verify |
Official source |
Page |
| D1 |
Whether the DRLP must be a corporate officer; how many DRLPs required |
State entity-licensing rules |
DRLP |
| D2 |
Whether the state requires affiliation/termination notices for entities |
State entity-licensing guidance |
Business-entity licensing |
| D3 |
Certificate-of-authority / “conducting business” thresholds for a DE entity into WA / CA / NY |
Each state’s Secretary of State + DOI |
Corporate prerequisites |
| D4 |
Whether SecState filing is a hard prerequisite to DOI licensing |
State SoS + DOI |
Corporate prerequisites |
| D5 |
Current CA agency-name pre-approval process, turnaround, restricted-word list |
CA DOI name unit + CA SoS bizfile |
California |
| D6 |
Exact current CA license-type names and bundling |
CA DOI license-type definitions |
California |
| # |
Verify |
Official source |
Page |
| E1 |
Whether WA / CA / NY require separate MGA licensing/registration, a bond, premium thresholds, carrier-contract requirements |
State DOI + state MGA Act / NAIC Model #225 |
What is an MGA |
| E2 |
Surplus-lines broker license prerequisites, premium-tax rates, stamping-office filings per state |
State DOI surplus-lines section + state stamping office (SLA-CA / ELANY) |
Surplus lines |
| E3 |
Whether the specific Tech-E&O-for-healthcare-AI program must be non-admitted per state |
State DOI + licensing counsel |
Surplus lines |
| E4 |
Appointment requirement/fee/timing; whether appointment must precede solicitation |
State DOI + NIPR appointment processing |
Appointment |
| E5 |
TPA / claims-adjuster licensing requirements per state |
State DOI adjuster/TPA pages |
TPA |
| # |
Verify |
Official source |
Page |
| F1 |
Statute citations for each state’s Unfair Trade Practices Act |
RCW Title 48 (WA) / CA Insurance Code / NY Insurance Law |
Ethics & trade practices |
| F2 |
Statute citations for each state’s Unfair Claims Settlement Practices Act |
Same as F1 |
Ethics & trade practices |
| F3 |
Whether/how rebating is permitted per state |
State insurance code |
Ethics & trade practices |
| F4 |
Adoption/amendment status of Model 218 and MGA Act #225 in WA / CA / NY |
NAIC model-law database + state code |
NAIC & Model 218 |
| # |
Verify |
Official source |
Page |
| G1 |
Life/annuity tax figures (MEC 7-pay, contribution limits, exclusion ratio rules) |
IRS current-year publications (irs.gov) |
Annuities |
| G2 |
Medicare/Medicaid/ACA/COBRA/HIPAA specifics & dollar amounts |
CMS (cms.gov) + current federal guidance |
Health coverages |
| G3 |
Current ISO/state property form editions (HO/DP/BPP) |
Vendor content outline + state filings |
Property coverages |
| G4 |
FINRA series required for variable products |
FINRA.org |
Life policy types |
| # |
Verify |
Official source |
Page |
| H1 |
Current count of states adopting the NAIC AI Model Bulletin; whether WA / CA / NY adopted it |
NAIC adoption tracker (naic.org) + state regulators |
AI Model Bulletin |
| H2 |
Exact title/date of the NAIC AI Model Bulletin |
Official NAIC bulletin |
AI Model Bulletin |
| H3 |
NAIC survey AI-adoption percentages + bias-testing-gap finding |
NAIC Big Data & AI (H) WG survey |
AI Model Bulletin |
| H4 |
Status of the AI Systems Evaluation Tool + early-2026 pilots |
NAIC Big Data & AI (H) WG |
Evaluation tool |
| H5 |
Whether a comprehensive AI model law and/or third-party model law (with vendor licensing) was introduced in 2026 |
NAIC dockets (naic.org) |
Evaluation tool |
| H6 |
Colorado AI Act (SB 24-205) effective date, amendments, applicability |
Colorado General Assembly + Division of Insurance |
Evaluation tool |
| H7 |
Current docket status of Kelly v. State Farm and Kisting-Leung v. Cigna |
Federal court dockets (PACER) |
AI claims litigation |
| H8 |
EU AI Act treatment of insurance as “high-risk” + transparency timeline |
EU AI Act (Reg. (EU) 2024/1689) |
Evaluation tool |
| H9 |
Current WA / CA / NY state-specific AI insurance bulletins/guidance (e.g., NY DFS ECDIS) |
WA OIC / CA DOI / NY DFS |
New York |
| # |
Verify |
Official source |
Page |
| I1 |
Westmont cost/timeline estimates (~$40–50k producer; ~$80–90k incl. surplus lines; ~4 months; ~40% fee) — labeled “estimates, subject to change” |
Current written Westmont quote (westmontlaw.com) + live state fees via NIPR |
On-ramp / critical path |
| I2 |
Whether Glacis (as a model/data vendor) will face direct licensing under the forthcoming NAIC third-party model law, and where |
NAIC Third-Party Data & Models (H) WG + enacted state law (+ counsel) |
On-ramp / critical path |
Volume 2 is grounded in a draft brochure, a positioning checklist, and internal
KB notes — every date, count, price, cite, and statistic below is tier iii of the
claim taxonomy: never assert
as current fact.
| # |
Verify |
Official source |
Page |
| J1 |
Demo Day date — and every other program/submission date in the draft application |
Current Lloyd’s Lab correspondence + program owner (ask Joe) |
Claim taxonomy |
| J2 |
Design-partner count (a point-in-time standing claim from a draft) |
Current pipeline / commercial materials (ask Joe) |
Claim taxonomy |
| J3 |
ISO 42001 control-coverage statistics — “a majority of controls” is the ceiling until re-checked against a current assessment |
Current mapping-engine assessment output |
Composite case study |
| J4 |
Self-serve pricing strings and packaging — published tier figures are brand-kit copy, not a live price list |
Current commercial/pricing materials (ask Joe) |
Pricing conversation |
| J5 |
Litigation cites (Sharp HealthCare; Washington v. Sutter Health) — names, status, disposition |
Court dockets (PACER / state courts) |
Why healthcare first |
| J6 |
Patent status — claimed IP is not granted IP; filing status changes |
USPTO records + patent counsel |
Claim taxonomy |
| J7 |
Corgi Insurance funding figure (reported ≈$108M) + the dedicated-AI-MGA entrant landscape it signals |
Funding announcements / press at time of use |
The unpriced risk |
(Resolved and retired from this list: the OVERT acronym expansion. Canonical is the
brand kit’s “Observable Verification Evidence for Runtime Trust”; the draft brochure’s
“Open Verifiable Evidence at Runtime” is a known erratum — see
What OVERT is.)
This wiki is a study aid, not legal or licensing advice. Confirm every item above
with the relevant regulator (WA OIC, CA DOI, NY DFS), the exam vendor’s current
candidate handbook, NAIC/NIPR, and qualified professional advisors before acting.
→ Wiki index
Drill this page →57 bank questions stand behind what you just read. Check it while it’s warm.